ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Sanofi-Synthelabo UK Limited

Sanofi-Synthelabo UK Limited is an active company incorporated on 16 May 1961 with the registered office located in Reading, Berkshire. Sanofi-Synthelabo UK Limited was registered 64 years ago.
Status
Active
Active since incorporation
Company No
00692858
Private limited company
Age
64 years
Incorporated 16 May 1961
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 31 December 2024 (8 months ago)
Next confirmation dated 31 December 2025
Due by 14 January 2026 (4 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2023 (12 months)
Accounts type is Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (3 months remaining)
Learn more about Sanofi-Synthelabo UK Limited
Contact
Address
410 Thames Valley Park Drive
Reading
Berkshire
RG6 1PT
England
Same address for the past 6 years
Telephone
01483505515
Email
Available in Endole App
See All Contacts
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Rippondeep Ubhi
Director • Managing Director • British • Lives in UK • Born in Dec 1978
Usman Khan
Director • Accountant • British • Lives in UK • Born in Jun 1979
Sanofi
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Fisons Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Aventis Pharma Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Rhone-Poulenc Rorer Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
May & Baker Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Sanofi-Aventis UK Holdings Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
RPR (Us) Limited
Rippondeep Ubhi and Usman Khan are mutual people.
Active
Aventis Pharma Holdings Limited
Usman Khan and Rippondeep Ubhi are mutual people.
Active
Genzyme Therapeutics Limited
Rippondeep Ubhi and Usman Khan are mutual people.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
31 Dec 2023
For period 31 Dec ⟶ 31 Dec 2023
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Decreased by 2 (-100%)
Total Assets
£256.24M
Increased by £4.16M (+2%)
Total Liabilities
£0
Same as previous period
Net Assets
£256.24M
Increased by £4.16M (+2%)
Debt Ratio (%)
0%
Same as previous period
See 10 Year Full Financials
Latest Activity
Rippon Ubhi Details Changed
3 Months Ago on 14 May 2025
Confirmation Submitted
7 Months Ago on 9 Feb 2025
Full Accounts Submitted
1 Year 2 Months Ago on 6 Jul 2024
Rippon Ubhi Appointed
1 Year 6 Months Ago on 1 Mar 2024
Jessamy Rachel Baird Resigned
1 Year 6 Months Ago on 1 Mar 2024
Confirmation Submitted
1 Year 7 Months Ago on 1 Feb 2024
Full Accounts Submitted
2 Years 1 Month Ago on 18 Jul 2023
Confirmation Submitted
2 Years 8 Months Ago on 6 Jan 2023
Sanofi (PSC) Details Changed
2 Years 10 Months Ago on 7 Nov 2022
Full Accounts Submitted
3 Years Ago on 18 Jul 2022
Get Alerts
Get Credit Report
Discover Sanofi-Synthelabo UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Second filing for the appointment of Rippondeep Ubhi as a director
Submitted on 27 May 2025
Director's details changed for Rippon Ubhi on 14 May 2025
Submitted on 19 May 2025
Confirmation statement made on 31 December 2024 with no updates
Submitted on 9 Feb 2025
Full accounts made up to 31 December 2023
Submitted on 6 Jul 2024
Appointment of Rippon Ubhi as a director on 1 March 2024
Submitted on 3 Mar 2024
Termination of appointment of Jessamy Rachel Baird as a director on 1 March 2024
Submitted on 1 Mar 2024
Confirmation statement made on 31 December 2023 with no updates
Submitted on 1 Feb 2024
Full accounts made up to 31 December 2022
Submitted on 18 Jul 2023
Confirmation statement made on 31 December 2022 with no updates
Submitted on 6 Jan 2023
Change of details for Sanofi as a person with significant control on 7 November 2022
Submitted on 22 Dec 2022
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs